InSilicoTrials and Delta Healthcare open their first branch in Limburg
Italian biotech company InSilicoTrials and Belgian-Dutch Delta Healthcare Consulting will soon establish themselves in Limburg. POM Limburg is bringing two new occupants to the Health Campus in Diepenbeek. The arrival of the two players marks another strengthening of the ecosystem.
Italy’s InSilicoTrials offers a cloud platform to pharma companies, which generates simulations when developing new drugs. InSilicoTrials currently employs about 20 people and has offices in Italy, the Netherlands and the United States. With its fourth branch on the Health Campus – employing five people – InSilicoTrials mainly aims to establish new collaborations with companies. Belgian-Dutch Delta Healthcare Consulting – which has some 13 employees – currently operates from Willebroek, but will move five people to the Health Campus. Delta supports clinical trials for the pharmaceutical industry and hospitals. The latter can hire study coordinators from them. Furthermore, Delta is the market leader in Belgium and the Netherlands in home visits for clinical trials.
Age
InSilicoTrials is currently working with biomedical company Rejuvenate Biomed, which develops drugs to delay the onset of age-related symptoms. Rejuvenate will use InSilicoTrials’ cloud platform to run a number of simulations. These are the types of collaborations that convinced the new occupants to settle in Limburg. CEO Luca Emili: “We opted for the Health Campus to make new connections with a wide range of stakeholders and innovate the healthcare of the future. The campus’ focus on new technological developments and digital solutions provides an ideal testing ground for our software platform.” Delta Healthcare CEO Geert Briers is similarly pleased: “For our second branch, we explicitly opted for the Health Campus due to its ambitious plans and the many opportunities for collaboration.”
Growing ecosystem
The arrival of the two residents will give a boost to the growing Health Campus ecosystem. Tom Vandeput, Deputy for the Economy and Chairman of POM Limburg: “The tally stands at seven new players who confirmed their arrival on campus, with InSilicoTrials being the third international one. Those companies certainly don’t arbitrarily choose their locations. The innovative environment we are creating, and the strong ecosystem around healthcare that we are building at the Health Campus, play a crucial role in our appeal. With their services, InSilicoTrials and Delta are yet another excellent addition to our ecosystem.”
BioVille
In the short term, InSilicoTrials and Delta Healthcare will move into health incubator BioVille. Just this year, that incubator will expand by 2,000 m².
